The Impact of Benzodiazepine Use on Mortality among Polysubstance Users in Vancouver, Canada
- 1 May 2016
- journal article
- research article
- Published by SAGE Publications in Public Health Reports®
- Vol. 131 (3) , 491-499
Abstract
Objective.: Illicit drug use is a well-established risk factor for increased morbidity and mortality. However, little is known about the impact of benzodiazepine use on mortality among populations of polysubstance users. This study aimed to identify the effect of benzodiazepine use on mortality among a prospective cohort of people in Canada who inject drugs (PWID). Methods.: A cohort of PWID in Vancouver, Canada, was prospectively followed from May 1996 through November 2013. Data on participants were linked to the provincial vital statistics registry to ascertain mortality rates and causes of death. Multivariable extended Cox regression with time-dependent variables was used to investigate the relationship between benzodiazepine use and time to all-cause mortality. Results.: During the study period, 2,802 participants were followed for a median of 67 months (interquartile range: 25–107). In total, 527 (18.8%) participants died, for an incidence density of mortality of 2.9 (95% confidence interval [CI] 2.7, 3.2) deaths per 100 person-years. After adjusting for HIV infection and other potential confounders, benzodiazepine use was independently associated with increased all-cause mortality (adjusted hazard ratio = 1.86, 95% CI 1.38, 2.51) and had a higher risk for mortality than all other traditional substances of abuse among this population. Results were consistent when non-overdose mortality was considered. Conclusion.: In this setting, benzodiazepine use was more strongly associated with mortality than any other substance of abuse. Greater recognition of the safety concerns related to benzodiazepines and strategies to prevent diversion to illicit use are needed.Keywords
This publication has 34 references indexed in Scilit:
- Mortality among people who inject drugs: a systematic review and meta-analysisBulletin of the World Health Organization, 2013
- Clinical Implications of Drug Abuse EpidemiologyPsychiatric Clinics of North America, 2012
- Social and Environmental Predictors of Plasma HIV RNA Rebound Among Injection Drug Users Treated With Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997–2007British Journal of Clinical Pharmacology, 2011
- Dose-response Effect of Incarceration Events on Nonadherence to HIV Antiretroviral Therapy Among Injection Drug UsersThe Journal of Infectious Diseases, 2011
- Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodoneCanadian Medical Association Journal, 2009
- A systematic review of research examining benzodiazepine‐related mortalityPharmacoepidemiology and Drug Safety, 2009
- Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyondPharmacology Biochemistry and Behavior, 2008
- Determinants of overdose incidents among illicit opioid users in 5 Canadian citiesCanadian Medical Association Journal, 2004
- Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?European Neuropsychopharmacology, 1999